TLS data
 

Biocommunique

Corporate Newsletter

 
 

FDA Announces New Programs to Improve Quality and Lower Drug Costs

Wed Mar 13 06:52:00 GMT 2019

Proposed program would promote development and appropriate use of consensus standards to help expedite pharmaceutical development.

Read More

Newest Round of California Competes Tax Credit Applications Due March 25th

Wed Mar 13 05:30:00 GMT 2019

The program offers corporate income tax credits for companies interested in relocating to or growing in California.

Read More

Biocom's Policy Staff Presents on East Bay Life Science Ecosystem

Wed Mar 13 05:11:00 GMT 2019

Melanie Cohn, Director of Regional Policy and Government Affairs, discussed East Bay's vibrancy and Biocom's plans for future growth.

Read More

Hearings to Begin on New State Legislation, Industry Faces Several Challenges

Wed Mar 13 05:00:00 GMT 2019

Included in the bills is AB 1468, a $100 million tax on opioid manufacturers as well as consumer privacy measures.

Read More

State Assemblyman, California Attorney General Introduce Bill to Ban Drug Patent Settlements

Wed Mar 13 04:44:00 GMT 2019

AB 824 seeks to ban patent settlements between generic companies looking to challenge validity of an innovator patent.

Read More

Request for Comments on FDA’s Real World Evidence Framework

Wed Mar 13 04:38:00 GMT 2019

Please submit your feedback on the draft to inform FDA on requirements and process of the RWE Program.

Read More

Pharma Execs Testify at Senate Finance Committee Drug Pricing Hearing

Wed Mar 13 04:30:00 GMT 2019

Execs testified and answered questions regarding drug pipeline, pricing strategies, and drug reform bills.

Read More

Biocom Invites You to a Legislative Roundtable with Congressman Mike Levin on March 20th

Tue Mar 12 04:50:00 GMT 2019

Come discuss important issues that directly affect our industry during an intimate roundtable with Congressman Mike Levin.

Read More

Potential Drug and Device Takeback Regulations Begin Process

Thu Feb 14 00:27:00 GMT 2019

All California drug and device manufacturers are now required to provide a list or drugs and sharps they sell within the state by April of this year.

Read More

Governor Newsom Delivers State of State Address

Thu Feb 14 00:19:00 GMT 2019

Catch the highlights from Governor Gavin Newsom's State of the State address.

Read More

Congress Holds First Hearings on Drug Pricing

Thu Feb 14 00:15:00 GMT 2019

Hearings focused on the rising prices of insulin and the impact it has on patients.

Read More

Biocom Opposes Changes to Coverage of Protected Classes Drugs

Thu Feb 14 00:10:00 GMT 2019

Read the concerns expressed regarding proposed changes to protected classes within Biocom's submitted comments.

Read More
 
172
 
 

Stay in the know with the Biocommunique

Sign up for Biocom's monthly newsletter to get all the latest life science news sent directly to your inbox.